Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma

Published:2014-05 Issue:5 Volume:106 Page:
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Kaseb Ahmed O.,Xiao Lianchun,Hassan Manal M.,Chae Young Kwang,Lee Ju-Seog,Vauthey Jean-Nicolas,Krishnan Sunil,Cheung Sheree,Hassabo Hesham M.,Aloia Thomas,Conrad Claudius,Curley Steven A.,Vierling John M.,Jalal Prasun,Raghav Kanwal,Wallace Michael,Rashid Asif,Abbruzzese James L.,Wolff Robert A.,Morris Jeffrey S.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/5/dju088/17985752/dju088.pdf

Reference35 articles.

1. Remote results of portal surgery in liver cirrhosis;Child;Rev Int Hepatol,1964

2. Transection of the oesophagus for bleeding oesophageal varices;Pugh;Br J Surg,1973

3. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J Natl Cancer Inst,2008

4. Pretreatment assessment of hepatocellular cancer: expert consensus conference;Wilson;HPB (Oxford),2010

5. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement;Vauthey;HPB (Oxford),2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features;The Oncologist;2023-12-30

2. Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor;PLOS ONE;2022-11-14

3. Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma;Frontiers in Oncology;2022-10-06

4. Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2022-10

5. HepatoScore ‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk;Hepatology;2021-06